Investors

Investment case

Why should you invest in Enzymatica?

✓ A solid scientific base and knowledge, verified via in vitro and clinical studies of the ColdZyme Mouth Spray.

✓ Unique patented product that addresses the cause of colds, while most other cold products only provide symptomatic relief.

✓ Proven success on the Swedish home market through continual growth since the launch in 2013.

✓ Scalable business model based on partnerships with successful international distributors with strong market prescence.